Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Expanded use of Visudyne approved by Canadian authorities

July 30, 2001

New compounds from Alcon particularly useful for treatment of dry eye

July 18, 2001

Allergan claims new cyclopentane derivatives for glaucoma management

July 12, 2001

Ad-vIL-10 as a promising strategy for human uveitis

July 11, 2001

ISTA completes enrollment in second phase III study of Vitrase

July 6, 2001

Vernalis and Alcon enter glaucoma alliance

July 5, 2001

Allergan and Inspire collaborate on development of two ophthalmic products for dry eye

July 2, 2001

ISTA completes enrollment in phase III study of Vitrase

July 2, 2001

EntreMed and NEI study Panzem in age-related macular degeneration

June 26, 2001

Receptor subtype-selective muscarinic agonist compares favorably with pilocarpine in primates

June 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...